Exousia Bio LMMY Cash Flow Statement (2022-2026)

OTC LMMY
$0.02 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT
Reported Financials

Exousia Bio Quarterly Cash Flow Statement

Periods 16 quarters
Latest Feb 2026

Exousia Bio cash flow statement data for the quarter ended Feb 2026. This cash flow statement covers 16 quarters of results from May 2022 through Feb 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026
Operating Activities
Net Income -0.01M-0.01M-0.01M-0.03M-0.01M0.00M0.00M-0.01M0.00M0.08M0.08M-0.03M-0.03M-0.02M-0.02M
Depreciation and DepletionDep. & Depletion 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Depreciation & Amortization (CF)Dep. & Amort. 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Change in Working Capital
Change in ReceivablesChange Receivables 0.00M0.00M0.00M0.00M-0.01M-0.01M
Change in Accured ExpensesChange Accured Exp. 610.00535.00924.000.00M0.00M0.00M0.00M0.00M0.18M
Change in Other Operating AssetsOther Assets Change 0.05M0.00M-0.04M
Change in Other Operating LiabilitiesOther Liabilities Change 0.00M0.00M0.01M0.00M0.00M-0.03M0.03M-0.03M
Other Working Capital ChangesOther WC Changes 0.00M0.00M0.01M0.00M0.00M-0.08M0.03M0.01M
Cash from OperationsCash from Ops. -0.01M0.00M0.00M-0.02M-0.01M0.00M0.00M0.00M0.00M0.09M-0.09M0.00M0.17M
Investing Activities
Capital ExpendituresCapex 0.00M0.00M670.00
Change in Property, Plant and EquipmentChange in PP&E 0.00M0.00M-670.00
Change in IntangiblesChange Intangibless 0.00M0.00M
Cash from Investing ActivitiesCash from Investing 0.00M0.00M-22.05M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance 0.00M0.00M0.00M0.01M
Non-Current Debt 0.00M0.00M0.00M0.01M
Net Debt Issuances and RepaymentsNet Debt Issuance 0.00M0.00M0.00M0.01M
Change in Capital Stock
Common Stock IssuedStock Issued 0.00M0.02M
Net Shares Issued and RepurchasedNet Shares Issued 0.00M0.02M
Net Equity Issued and RepurchasedNet Equity Issued 0.00M0.02M0.00M
Cash from Financing ActivitiesCash from Financing 975.000.00M0.00M0.03M0.00M0.00M0.00M0.00M-0.09M0.09M0.00M21.88M
Additional items
Change in Cash -0.01M-435.000.00M0.00M-0.01M-290.00-2.002.000.00M
Ending Cash Balance 0.01M0.00M0.00M0.01M0.00M
Free Cash FlowFCF -0.01M0.00M0.00M-0.02M-0.01M0.00M0.00M0.00M0.00M0.09M-0.09M0.00M0.17M
Net Cash FlowNCF -0.01M-435.000.00M0.00M-0.01M-290.00-2.002.000.00M-1.00

Exousia Bio Cash Flow Statement API

Pull Exousia Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=LMMY&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY